Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 1.00 |
| ▸ | CA9 | Q16790 | 7/20 | 1.00 |
| ▸ | CA2 | P00918 | 5/20 | 1.00 |
| ▸ | CA1 | P00915 | 4/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | BCHE | P06276 | 1/20 | 1.00 |
| ▸ | CA6 | P23280 | 1/20 | 1.00 |
| ▸ | CA5A | P35218 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | RET | P07949 | 2/20 | 0.55 |
| ▸ | GRK5 | P34947 | 2/20 | 0.55 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.55 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL6033672 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL6049140 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL4199164 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL7073018 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL4777123 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL29358404 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL29191365 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL3816 | 1.00 | CA12 (1.00) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL9463482 | 0.98 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL435836 | 0.98 | CA12 (0.96) | CA12CA9CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102605-A1 | CONJUGATION OF SACCHARIDE ANTIGENS USING ACETOXYBOROHYDRIDES | MERCK SHARP & DOHME LLC (US) | 2024-05-16 | — | — | WO | claimed |
| CN-109925277-A | A kind of polysaccharide-based temperature-responsive nanogel and preparation method and application | 上海交通大学医学院附属第九人民医院 | 2019-06-25 | — | — | CN | claimed |
| CN-105348410-B | One kind polysaccharide containing iodine and its synthetic method and application | 中山大学 | 2019-02-26 | — | — | CN | claimed |
| EP-3394197-A1 | METHOD FOR PRODUCING COLORLESS AND AGING-RESISTANT, POLYACRYLATE-BASED PRESSURE-SENSITIVE ADHESIVE COMPOUNDS | tesa SE (DE) | 2018-10-31 | — | — | EP | claimed |
| EP-1506007-B1 | MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS | NOVARTIS VACCINES & DIAGNOSTIC (IT) | 2011-06-22 | — | — | EP | claimed |
| CN-101665542-A | Preparation method of sulfated polysaccharide | UNIV WUHAN | 2010-03-10 | — | — | CN | claimed |
| US-20060263390-A1 | Modified saccharides, conjugates thereof, and their manufacture | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2006-11-23 | — | — | US | claimed |
| EP-1534342-B1 | MODIFIED SACCHARIDES, CONJUGATES THEREOF, AND THEIR MANUFACTURE | CHIRON SRL (IT) | 2006-03-08 | — | — | EP | claimed |
| EP-1534342-A1 | MODIFIED SACCHARIDES, CONJUGATES THEREOF, AND THEIR MANUFACTURE | Chiron SRL. (IT) | 2005-06-01 | — | — | EP | claimed |
| WO-2004019992-A1 | MODIFIED SACCHARIDES, CONJUGATES THEREOF, AND THEIR MANUFACTURE | CHIRON SRL (IT) | 2004-03-11 | — | — | WO | claimed |
| CN-118146401-A | Passion fruit dietary fiber/nano zinc oxide composite film and preparation method and application thereof | 桂林理工大学 | 2024-06-07 | — | — | CN | disclosed |
| WO-2024102605-A1 | CONJUGATION OF SACCHARIDE ANTIGENS USING ACETOXYBOROHYDRIDES | MERCK SHARP & DOHME LLC (US) | 2024-05-16 | — | — | WO | disclosed |
| CN-117339555-A | Integral monolithic activated carbon adsorption material and application thereof | 张家港安储科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-114990168-B | Composition prepared by fermenting sour cherry and having good health care function and application of composition in health field | 灶灶科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-11169101-B2 | Oligosaccharide compositions and methods of use thereof | KALEIDO BIOSCIENCES, INC. (US) | 2021-11-09 | — | — | US | disclosed |
| US-5556781-A | DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1996-09-17 | — | — | US | disclosed |
| US-4965069-A | ALTERED PHYSICAL OR CHEMICAL STRUCTURE BY MEANS OF OXIDIZING AGENTS | CYTOGEN CORPORATION | 1990-10-23 | — | — | US | disclosed |
| US-4944952-A | Using galactosidase | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 1990-07-31 | — | — | US | disclosed |
| US-4853326-A | OXIDATION OF OLIGOSACCHARIDES WITH PERIODIC ACID | CYTOGEN CORPORATON (US) | 1989-08-01 | — | — | US | disclosed |
| US-4339239-A | TEXTILE DYE BATHS | MERCK & CO., INC. (US) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11169101-B2 | Oligosaccharide compositions and methods of use thereof | OGT, FUT5, FUT6 | CA12 257/4885CA9 403/4885CA2 2185/4885 |
| US-20060263390-A1 | Modified saccharides, conjugates thereof, and their manufacture | C9, B3GNT2, OGA | CA12 137/4885CA9 658/4885CA2 2867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.